ID   ITXi002-A-2
AC   CVCL_B5QF
SY   CRISPR-2 IRX5 D8 KO; IRX5-KO
DR   BioSamples; SAMEA11025521
DR   hPSCreg; ITXi002-A-2
DR   Wikidata; Q111733529
RX   PubMed=34929443;
CC   From: Institut du Thorax; Nantes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 14361; IRX5.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5QD ! ITXi002-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=34929443; DOI=10.1016/j.scr.2021.102627;
RA   Canac R., Caillaud A., Cimarosti B., Girardeau A., Hamamy H.,
RA   Reversade B., Bonnard C., Al Sayed Z.R., David L., Poschmann J.,
RA   Lemarchand P., Lamirault G., Gaborit N.;
RT   "Generation of three human induced pluripotent stem cell lines with
RT   IRX5 knockout and knockin genetic editions using CRISPR-Cas9
RT   system.";
RL   Stem Cell Res. 58:102627-102627(2022).
//